Prostate Cancer - Results from #23320

Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: A pharmacogenetic assessment of outcome and toxicity - Abstract June 26, 2013

Charles G. Drake, MD, PhD of Johns Hopkins Kimmel Cancer Center takes time to share his understanding on the rationale for implementing immunotherapy in the treatment of prostate cancer June 25, 2013

Large-cell neuroendocrine carcinoma of prostate. Case report - Abstract June 25, 2013

Safety of megestrol acetate in palliating anorexia-cachexia syndrome in patients with castration-resistant prostate cancer - Abstract June 25, 2013

Preoperative erectile function is an independent predictor for decision to spare cavernous nerves during radical prostatectomy - Abstract June 25, 2013

Differences in prostate cancer detection rates according to the level of glomerular filtration rate in patients with prostate specific antigen levels of 4.0–10.0 ng/ml - Abstract June 25, 2013

Locally advanced prostate cancer: Current controversies and optimisation opportunities - Abstract June 25, 2013

The predictive value of endorectal 3-Tesla multiparametric MRI for extraprostatic extension in low-, intermediate and high-risk prostate cancer patients - Abstract June 25, 2013

Expanded criteria to identify men eligible for active surveillance of low-risk prostate cancer at Johns Hopkins: A preliminary analysis - Abstract June 25, 2013

Coffee consumption and the risk of overall and fatal prostate cancer in the NIH-AARP Diet and Health Study - Abstract June 25, 2013

Evaluation of extraprostatic disease in the staging of prostate cancer by F-18 choline PET/CT: Can PSA and PSA density help in patient selection? - Abstract June 25, 2013

High-risk prostate cancer: Combination of high-dose, high-precision radiotherapy and androgen deprivation therapy - Abstract June 24, 2013

Plasma-seq: A novel strategy for metastatic prostate cancer analysis - Abstract June 24, 2013

Treatment of local-regional prostate cancer detected by PSA screening: Benefits and harms according to prognostic factors - Abstract June 24, 2013

Coffee consumption and the risk of prostate cancer: The Ohsaki Cohort Study - Abstract June 24, 2013

MR imaging of prostate cancer in radiation oncology: What radiologists need to know - Abstract June 24, 2013

Methotrexate therapy leading to a rapid progression of a previously indolent prostate cancer: Is immunosuppression to blame? - Abstract June 24, 2013

A performance analysis of the presence of malignant circulating prostate cells as a predictive factor for the detection of prostate cancer in the first, second and third prostate biopsy - Abstract June 24, 2013

Outcome of radical prostatectomy in patients meeting criteria for active surveillance - Abstract June 24, 2013

Does periprostatic block increase the transrectal ultrasound (TRUS) biopsy sepsis rate in men with elevated PSA? - Abstract June 24, 2013

Page 1167 of 1458